Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
Answer first: what SUD operators should do this week
If you run a Medicaid-dominant SUD platform, treat the June 4, 2026 federal indictment of Addiction Recovery Care founder Timmy G. Robinson Jr. As the trigger to pressure-test billing integrity, board governance, and CEO succession before a federal subpoena lands on your desk. Boards that wait will react from behind. Founders who assume this is a Kentucky story will miss the point.
According to the U.S. Attorney’s Office for the Eastern District of Kentucky, Robinson, 50, was indicted for one count of wire fraud and two counts of money laundering. The alleged conduct is not Medicaid billing fraud. Prosecutors allege Robinson caused ARC to sell the same Employee Retention Credit rights to two different buyers. Per the indictment, a first buyer made a $2.7 million advance payment in July 2025 for ARC’s rights to an anticipated ERC refund based on first-quarter 2021 payroll, and a second buyer paid a $4.7 million advance on November 12, 2025 after Robinson falsely represented that the assets had not previously been sold or encumbered. When the IRS issued the ERC payments to ARC in December 2025, Robinson directed ARC not to repay either buyer.
The exposure is real. Robinson faces up to 20 years in prison on the wire fraud charge and 10 years on each money laundering count. He pleaded not guilty on June 17 in Ashland, with trial scheduled for August. Robinson resigned as CEO after the grand jury indictment; Cassandra Webb, president and COO, stepped in as interim chief executive.
Why federal scrutiny lands on dominant Medicaid SUD operators
Federal investigators look for billing patterns that do not look like anybody else’s. A federal database reviewed by Louisville Public Media and the Lexington Herald-Leader showed ARC was paid $70 million from Medicaid for a single psychoeducation service in 2023 and 2024, which accounted for 20% of all Medicaid payments under that billing code in the entire country for that two-year period. One provider, one code, one fifth of the national spend. That is the kind of signal that puts HHS-OIG, the FBI Louisville Field Office, and the Eastern District of Kentucky U.S. Attorney’s Office in motion.
Jason Parman, First Assistant United States Attorney for the Eastern District of Kentucky; Karen Wingerd, Special Agent in Charge, IRS-Criminal Investigations, Detroit Field Division; and Olivia Olson, Special Agent in Charge, FBI Louisville Field Office, jointly announced the indictment. The broader FBI investigation of ARC for potential Medicaid billing fraud remains ongoing.
Now layer on the macro numbers. On January 16, 2026, DOJ announced that False Claims Act settlements and judgments exceeded $6.8 billion in the fiscal year ending September 30, 2025, the highest amount in a single year in the history of the statute. Whistleblowers filed 1,297 qui tam lawsuits, the highest number ever, and the government opened 401 investigations. Of the more than $6.8 billion, over $5.7 billion related to matters that involved the health care industry.
Deputy Attorney General Todd Blanche put it directly: “Stopping rampant fraud is a top priority, and this record-breaking year proves the False Claims Act remains one of the government’s most powerful weapons against fraud.” If your CFO cannot tell the board what percentage of revenue comes from any single CPT or HCPCS code, you have a problem. If your utilization management team cannot explain why your average length of stay, weekly hour delivery, or step-down rates differ from peers in Florida, Ohio, or Tennessee, that is the gap a relator or auditor will fill for you.
A board-level operating playbook for the next 60 days
Directors typically learn about a federal investigation the same week the press does. Too late to design governance. The HHS-OIG 2023 General Compliance Program Guidance makes the board’s role explicit, recommending annual internal risk assessments, treating quality of care as a component of the compliance program, and emphasizing board and executive oversight.
Here is what AHS walks boards through when a peer indictment hits the news:
- Emergency CEO succession protocol. Directors should name an interim CEO, a board-designated compliance liaison, and an outside counsel point of contact within 72 hours. Document the authority delegation in writing. Do not let signature authority and bank access drift.
- Independent compliance review. Engage an outside reviewer, not the firm that drafted your existing policies, to conduct a focused 60-day chart audit and billing claims sample. Sample by payer, by level of care (PHP as ASAM Level 2.5 outpatient, IOP, residential, and residential withdrawal management), and by referral source.
- Document hold and data preservation. Issue a written litigation hold covering EMR data, billing logs, attendance records, marketing contracts, and text messages. Confirm your EMR vendor can support a forensic export.
- Leadership attestations. Directors should require the CEO, CFO, CCO, and clinical director to sign quarterly attestations confirming personal review of compliance metrics.
- Compliance officer reporting line. The GCPG states that the compliance officer should not lead or report to legal or financial functions. If yours reports to billing or legal, fix it this month.
CIA-readiness, IRO selection, and the PE sponsor angle
Directors and executives should treat Corporate Integrity Agreements as the operating system DOJ and HHS-OIG impose when they no longer trust an operator’s internal controls. Getting CIA-ready before you need one is the play. That means a written compliance work plan, a functional Independent Review Organization bench, a documented claims sampling methodology, and a board compliance committee charter that actually meets. When selecting an IRO, look for prior CIA engagement experience, behavioral health domain knowledge, statistician credentials for claims sampling, and zero financial entanglement with your billing or EMR vendors.
For PE sponsors, the warning has been delivered. At the February 22, 2024 Federal Bar Association Qui Tam Conference, then-Principal Deputy Assistant Attorney General Brian Boynton stated that investors, such as private equity firms or venture capital firms, “may influence patient care by providing express direction for how a provider should conduct their business, or more indirectly by providing revenue targets or other indirect benchmarks intended to prioritize reimbursement.” He added that if an investor knowingly engages in conduct that causes the submission of false claims, they may subject themselves to liability.
The HHS-OIG 2023 GCPG echoes the point. OIG calls out the growing presence of private equity and other forms of private investment in health care and recommends that such investors scrutinize their operations and oversight to ensure compliance with fraud and abuse laws and the delivery of high-quality care. If your sponsor’s investment committee is setting EBITDA targets that only pencil if utilization management approves every admission, that is your diligence question.
Specific controls to install before a federal cloud forms
Operators asking what to actually do differently by Friday, start here.
- Concentration analytics. Monthly board report on revenue by CPT/HCPCS code, by payer, and by referring marketing channel. If a single code approaches ARC’s psychoeducation profile (a fifth of a national code’s spend flowing to one provider), your CFO should be the first to raise it, not a relator.
- ASAM Criteria 4th Edition medical necessity documentation tied to admission and continued stay for SUD, with a separate LOCUS workflow for co-occurring mental health.
- Weekly hour reconciliation for PHP (outpatient, ASAM Level 2.5) and IOP before any claim is submitted. Attendance must support billed hours, per session, per patient.
- EKRA (18 U.S.C. § 220) review of every marketing, call center, and lead-generation contract. Compensation tied to head count remains the single most common red flag.
- Joint Commission or CARF survey readiness as a baseline, not as a sprint. Accreditors and federal investigators ask overlapping questions about medical necessity, documentation, and governance.
The Robinson indictment happens to involve an ERC tax credit scheme in Kentucky. The lesson for operators in Florida, Ohio, Tennessee, or any other jurisdiction is broader. Since Kentucky’s cuts to Medicaid payments for certain services, and the launch of the FBI investigation in 2024, ARC has laid off employees and closed most of its clinics. The founder tried to sell the company in part to pay a draft DOJ settlement, and that deal was put on hold at the beginning of the year, quickly followed by a lender suing ARC in a New York federal court for defaulting on a loan repayment. When a founder-led Medicaid platform hits financial distress, billing pressure compounds. Directors and CEOs need to see both before the FBI does.
Frequently asked questions
What specific charges did federal prosecutors bring against ARC founder Tim Robinson?
According to the U.S. Attorney’s Office for the Eastern District of Kentucky, Timmy G. Robinson Jr., 50, was indicted on June 4, 2026 on one count of wire fraud and two counts of money laundering tied to selling the same ARC Employee Retention Credit rights to two different buyers. A first buyer paid ARC a $2.7 million advance in July 2025, and a second buyer paid a $4.7 million advance on November 12, 2025 after Robinson falsely represented the assets were unencumbered. If convicted, the wire fraud count carries a maximum of 20 years and each money laundering count up to 10 years. Robinson pleaded not guilty on June 17, 2026 in Ashland, and his trial is scheduled for August.
How should a behavioral health board structure emergency CEO succession when the founder is under federal indictment?
Within 72 hours, directors should appoint an interim CEO, separate signature and banking authority from the founder, issue a written litigation hold covering EMR data and billing records, retain independent outside counsel (not the founder’s longtime firm), and authorize an independent compliance review. Directors should document every step in board minutes and communicate with payers, accreditors, and the state Medicaid agency before those parties call. The HHS-OIG 2023 General Compliance Program Guidance recommends that the compliance officer report outside the legal and finance chain of command and have direct access to the board.
What billing patterns most often trigger federal SUD fraud investigations?
Revenue concentration in a single high-margin code that exceeds peer norms is a leading trigger. A federal database reviewed by Louisville Public Media showed ARC was paid roughly $70 million from Medicaid for one psychoeducation service in 2023 and 2024, or about 20% of all Medicaid payments under that billing code nationwide over the two-year period. Other analytics-driven triggers include atypical average length of stay, weekly hour delivery, step-down rates, and marketing spend concentrated with single lead-generation vendors compensated per head.
Are private equity sponsors personally exposed under the False Claims Act if a portfolio company submits fraudulent claims?
Yes, potentially. At the February 2024 Federal Bar Association Qui Tam Conference, then-Principal Deputy AAG Brian Boynton stated that private equity and venture capital investors who provide express direction on how a provider conducts its business, or set revenue targets or benchmarks intended to prioritize reimbursement, may face FCA liability if they knowingly engage in conduct that causes the submission of false claims. The HHS-OIG 2023 GCPG separately calls out private investors and recommends they scrutinize operations and oversight to ensure compliance with fraud and abuse laws.
References
- U.S. Attorney’s Office, Eastern District of Kentucky. Addiction Recovery Care Founder Indicted for Wire Fraud and Money Laundering (June 2026)
- IRS Criminal Investigation. Addiction Recovery Care Founder Indicted for Wire Fraud and Money Laundering
- DOJ Office of Public Affairs. False Claims Act Settlements and Judgments Exceed $6.8B in Fiscal Year 2025 (Jan. 16, 2026)
- HHS-OIG General Compliance Program Guidance (November 2023)
- DOJ. Principal Deputy AAG Brian M. Boynton Remarks at 2024 Federal Bar Association Qui Tam Conference
- Louisville Public Media. ARC owner Tim Robinson pleads not guilty to federal fraud charges (June 17, 2026)
- ProPublica / Lexington Herald-Leader. Founder of Kentucky Drug Rehab Center Indicted on Fraud and Money Laundering Charges